137 related articles for article (PubMed ID: 15833515)
1. Increased intratumoral expression of prostate secretory protein of 94 amino acids predicts for worse disease recurrence and progression after radical prostatectomy in patients with prostate cancer.
Girvan AR; Chang P; van Huizen I; Moussa M; Xuan JW; Stitt L; Chin JL; Yamasaki Y; Izawa JI
Urology; 2005 Apr; 65(4):719-23. PubMed ID: 15833515
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of prostate secretory protein of 94 amino acids and its binding protein after radical prostatectomy.
Reeves JR; Dulude H; Panchal C; Daigneault L; Ramnani DM
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6018-22. PubMed ID: 17062675
[TBL] [Abstract][Full Text] [Related]
3. PSP94 expression after androgen deprivation therapy: a comparative study with prostate specific antigen in benign prostate and prostate cancer.
Imasato Y; Xuan JW; Sakai H; Izawa JI; Saito Y; Chin JL; Moussa M
J Urol; 2000 Nov; 164(5):1819-24. PubMed ID: 11025776
[TBL] [Abstract][Full Text] [Related]
4. Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy.
Henshall SM; Horvath LG; Quinn DI; Eggleton SA; Grygiel JJ; Stricker PD; Biankin AV; Kench JG; Sutherland RL
J Natl Cancer Inst; 2006 Oct; 98(19):1420-4. PubMed ID: 17018789
[TBL] [Abstract][Full Text] [Related]
5. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
6. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.
Swindle P; Eastham JA; Ohori M; Kattan MW; Wheeler T; Maru N; Slawin K; Scardino PT
J Urol; 2005 Sep; 174(3):903-7. PubMed ID: 16093984
[TBL] [Abstract][Full Text] [Related]
7. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.
Hattab EM; Koch MO; Eble JN; Lin H; Cheng L
J Urol; 2006 May; 175(5):1695-9; discussion 1699. PubMed ID: 16600733
[TBL] [Abstract][Full Text] [Related]
8. Radical prostatectomy for clinical stage T3a disease.
Freedland SJ; Partin AW; Humphreys EB; Mangold LA; Walsh PC
Cancer; 2007 Apr; 109(7):1273-8. PubMed ID: 17315165
[TBL] [Abstract][Full Text] [Related]
9. Positive family history of prostate cancer not associated with worse outcomes after radical prostatectomy.
Lee KL; Marotte JB; Ferrari MK; McNeal JE; Brooks JD; Presti JC
Urology; 2005 Feb; 65(2):311-5. PubMed ID: 15708044
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence.
Karam JA; Lotan Y; Roehrborn CG; Ashfaq R; Karakiewicz PI; Shariat SF
Prostate; 2007 May; 67(6):614-22. PubMed ID: 17299799
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin D and epidermal growth factor receptor immunohistochemistry does not predict recurrence of prostate cancer in patients undergoing radical prostatectomy.
Moul JW; Maygarden SJ; Ware JL; Mohler JL; Maher PD; Schenkman NS; Ho CK
J Urol; 1996 Mar; 155(3):982-5. PubMed ID: 8583622
[TBL] [Abstract][Full Text] [Related]
12. Distinct patterns of endothelin axis expression in primary prostate cancer.
Godara G; Pecher S; Jukic DM; D'Antonio JM; Akhavan A; Nelson JB; Pflug BR
Urology; 2007 Jul; 70(1):209-15. PubMed ID: 17656249
[TBL] [Abstract][Full Text] [Related]
13. Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer?
van Oort IM; Schout BM; Kiemeney LA; Hulsbergen CA; Witjes JA
Eur Urol; 2005 Oct; 48(4):572-6. PubMed ID: 16046051
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
Rosenbaum E; Hoque MO; Cohen Y; Zahurak M; Eisenberger MA; Epstein JI; Partin AW; Sidransky D
Clin Cancer Res; 2005 Dec; 11(23):8321-5. PubMed ID: 16322291
[TBL] [Abstract][Full Text] [Related]
15. The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy.
Cheng L; Koch MO; Juliar BE; Daggy JK; Foster RS; Bihrle R; Gardner TA
J Clin Oncol; 2005 May; 23(13):2911-7. PubMed ID: 15860849
[TBL] [Abstract][Full Text] [Related]
16. Expression of major heat shock proteins in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy.
Kurahashi T; Miyake H; Hara I; Fujisawa M
J Urol; 2007 Feb; 177(2):757-61. PubMed ID: 17222676
[TBL] [Abstract][Full Text] [Related]
17. Impact of patient age on biochemical recurrence rates following radical prostatectomy.
Magheli A; Rais-Bahrami S; Humphreys EB; Peck HJ; Trock BJ; Gonzalgo ML
J Urol; 2007 Nov; 178(5):1933-7; discussion 1937-8. PubMed ID: 17868723
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of connexin43 expression in patients with clinically localized prostate cancer.
Benko G; Spajić B; Demirović A; Stimac G; Kru Sbreve Lin B; Tomas D
Prostate Cancer Prostatic Dis; 2011 Mar; 14(1):90-5. PubMed ID: 21173791
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.
Gupta A; Lotan Y; Ashfaq R; Roehrborn CG; Raj GV; Aragaki CC; Montorsi F; Shariat SF
Eur Urol; 2009 May; 55(5):1124-33. PubMed ID: 18585843
[TBL] [Abstract][Full Text] [Related]
20. Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer.
Sanderson KM; Penson DF; Cai J; Groshen S; Stein JP; Lieskovsky G; Skinner DG
J Urol; 2006 Nov; 176(5):2025-31; discussion 2031-2. PubMed ID: 17070244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
